AAP
AGIO icon

Arax Advisory Partners’s Agios Pharmaceuticals AGIO Stock Holding History

Arax Advisory Partners’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.06K Buy
120
+41
+52% +$1.16K ﹤0.01% 2884
2025
Q4 		$2.15K Sell
79
-623
-89% -$21.9K ﹤0.01% 3233
2025
Q3 		$28.2K Buy
702
+689
+5,300% +$25.9K ﹤0.01% 2115
2025
Q2 		$432 Sell
13
-7
-35% -$212 ﹤0.01% 2941
2025
Q1 		$586 Sell
20
-62
-76% -$2.06K ﹤0.01% 2512
2024
Q4 		$2.69K Sell
82
-34
-29% -$1.6K ﹤0.01% 1937
2024
Q3 		$5.15K Sell
116
-6
-5% -$272 ﹤0.01% 1703
2024
Q2 		$5.26K Buy
122
+108
+771% +$3.9K ﹤0.01% 1576
2024
Q1 		$409 Buy
+14
New +$375 ﹤0.01% 1245

Other funds holding AGIO

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return